Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Knox

Showing results (731-740 of 829) with videos related to

Pageof 83
Sort By:
European Urology|October 25, 2016
Efficacy of Second-line Targeted Therapy for Renal Cell Carcinoma According to Change from Baseline in International Metastatic Renal Cell Carcinoma Database Consortium Prognostic CategoryIan D Davis, Wanling Xie, Carmel Pezaro, et al.
Biorxiv : the Preprint Server for Biology|September 30, 2024
Immune perturbations in human pancreas lymphatic tissues prior to and after type 1 diabetes onsetGregory J Golden, Vincent H Wu, Jacob T Hamilton, et al.
Nature Communications|May 18, 2025
Immune perturbations in human pancreas lymphatic tissues prior to and after type 1 diabetes onsetGregory J Golden, Vincent H Wu, Jacob T Hamilton, et al.
Journal of Gastroenterology and Hepatology|February 5, 2016
Ledipasvir/sofosbuvir fixed-dose combination tablet in Taiwanese patients with chronic genotype 1 hepatitis C virusWan-Long Chuang, Rong-Nan Chien, Cheng-Yuan Peng, et al.
JAMA Oncology|October 1, 2020
Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib: The CheckMate 040 Randomized Clinical TrialThomas Yau, Yoon-Koo Kang, Tae-You Kim, et al.
Expert Opinion on Investigational Drugs|December 10, 2016
RRx-001: a systemically non-toxic M2-to-M1 macrophage stimulating and prosensitizing agent in Phase II clinical trialsBryan Oronsky, Ramasamy Paulmurugan, Kira Foygel, et al.
Oncology|October 14, 2020
Chemoradiotherapy Using Carboplatin plus Paclitaxel versus Cisplatin plus Fluorouracil for Esophageal or Gastroesophageal Junction CancerDi Maria Jiang, Hao-Wen Sim, Osvaldo Espin-Garcia, et al.
Journal of Medicinal Chemistry|December 22, 2018
Discovery of Indole- and Indazole-acylsulfonamides as Potent and Selective Na<sub>V</sub>1.7 Inhibitors for the Treatment of PainGuanglin Luo, Ling Chen, Amy Easton, et al.
Clinical Colorectal Cancer|November 13, 2017
Molecular Profiling of Patients With Advanced Colorectal Cancer: Princess Margaret Cancer Centre ExperienceJoanne W Chiu, Monika K Krzyzanowska, Stefano Serra, et al.
European Urology|June 20, 2016
Third-line Targeted Therapy in Metastatic Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database ConsortiumJ Connor Wells, Igor Stukalin, Craig Norton, et al.
Pageof 83

Showing results (731-740 of 829) with videos related to

Sort By:
Pageof 83
European Urology|October 25, 2016
Efficacy of Second-line Targeted Therapy for Renal Cell Carcinoma According to Change from Baseline in International Metastatic Renal Cell Carcinoma Database Consortium Prognostic CategoryIan D Davis, Wanling Xie, Carmel Pezaro, et al.
Biorxiv : the Preprint Server for Biology|September 30, 2024
Immune perturbations in human pancreas lymphatic tissues prior to and after type 1 diabetes onsetGregory J Golden, Vincent H Wu, Jacob T Hamilton, et al.
Nature Communications|May 18, 2025
Immune perturbations in human pancreas lymphatic tissues prior to and after type 1 diabetes onsetGregory J Golden, Vincent H Wu, Jacob T Hamilton, et al.
Journal of Gastroenterology and Hepatology|February 5, 2016
Ledipasvir/sofosbuvir fixed-dose combination tablet in Taiwanese patients with chronic genotype 1 hepatitis C virusWan-Long Chuang, Rong-Nan Chien, Cheng-Yuan Peng, et al.
JAMA Oncology|October 1, 2020
Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib: The CheckMate 040 Randomized Clinical TrialThomas Yau, Yoon-Koo Kang, Tae-You Kim, et al.
Expert Opinion on Investigational Drugs|December 10, 2016
RRx-001: a systemically non-toxic M2-to-M1 macrophage stimulating and prosensitizing agent in Phase II clinical trialsBryan Oronsky, Ramasamy Paulmurugan, Kira Foygel, et al.
Oncology|October 14, 2020
Chemoradiotherapy Using Carboplatin plus Paclitaxel versus Cisplatin plus Fluorouracil for Esophageal or Gastroesophageal Junction CancerDi Maria Jiang, Hao-Wen Sim, Osvaldo Espin-Garcia, et al.
Journal of Medicinal Chemistry|December 22, 2018
Discovery of Indole- and Indazole-acylsulfonamides as Potent and Selective Na<sub>V</sub>1.7 Inhibitors for the Treatment of PainGuanglin Luo, Ling Chen, Amy Easton, et al.
Clinical Colorectal Cancer|November 13, 2017
Molecular Profiling of Patients With Advanced Colorectal Cancer: Princess Margaret Cancer Centre ExperienceJoanne W Chiu, Monika K Krzyzanowska, Stefano Serra, et al.
European Urology|June 20, 2016
Third-line Targeted Therapy in Metastatic Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database ConsortiumJ Connor Wells, Igor Stukalin, Craig Norton, et al.
Pageof 83